Ignite Creation Date:
2024-05-06 @ 2:38 AM
Last Modification Date:
2024-10-26 @ 11:21 AM
Study NCT ID:
NCT02098967
Status:
COMPLETED
Last Update Posted:
2018-05-17
First Post:
2014-03-25
Brief Title:
A Study of the Safety and Pharmacokinetics of RO6839921 An MDM2 Antagonist in Patients With Advanced Cancers Including Acute Myeloid Leukemia
Sponsor:
Hoffmann-La Roche
Organization:
Hoffmann-La Roche
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-04-21
Start Date Type:
ACTUAL
Primary Completion Date:
2018-05-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-05-07
Completion Date Type:
ACTUAL
First Submit Date:
2014-03-25
First Submit QC Date:
March 25 2014
Study First Post Date:
2014-03-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-05-16
Last Update Post Date:
2018-05-17
Last Update Post Date Type:
ACTUAL